Free Trial
ASX:PSQ

Pacific Smiles Group (PSQ) Stock Price, News & Analysis

Pacific Smiles Group logo

About Pacific Smiles Group Stock (ASX:PSQ)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
5,251 shs
Average Volume
N/A
Market Capitalization
A$321.63 million
P/E Ratio
39.50
Dividend Yield
2.69%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PSQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pacific Smiles Group and its competitors with MarketBeat's FREE daily newsletter.

PSQ Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Pacific Smiles Group Ltd
Beam Bidco Strengthens Hold on Pacific Smiles
See More Headlines

PSQ Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Pacific Smiles Group investors own include SoFi Technologies (SOFI), Andersons (ANDE), British American Tobacco (BTI), Copa (CPA), FREYR Battery (FREY), CocaCola (KO) and Main Street Capital (MAIN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
ASX:PSQ
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
39.50
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$8.04 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$180.30 million
Price / Cash Flow
21.10
Book Value
A$0.38 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$321.63 million
Optionable
Not Optionable
Beta
1.00
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:PSQ) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners